PainReform Ltd. (PRFX)
NASDAQ: PRFX · Real-Time Price · USD
0.583
-0.058 (-9.08%)
At close: Oct 11, 2024, 4:00 PM
0.565
-0.018 (-3.04%)
After-hours: Oct 11, 2024, 7:39 PM EDT
PainReform Employees
PainReform had 7 employees as of December 31, 2023. The number of employees increased by 1 or 16.67% compared to the previous year.
Employees
7
Change (1Y)
1
Growth (1Y)
16.67%
Revenue / Employee
n/a
Profits / Employee
-$2,524,714
Market Cap
682.72K
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 7 | 1 | 16.67% |
| Dec 31, 2022 | 6 | 2 | 50.00% |
| Dec 31, 2021 | 4 | 2 | 100.00% |
| Dec 31, 2020 | 2 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Aditxt | 47 |
| LogicMark | 27 |
| Windtree Therapeutics | 20 |
| Seelos Therapeutics | 16 |
| Catheter Precision | 14 |
| GRI Bio | 4 |
| SciSparc | 3 |
PRFX News
- 4 weeks ago - PainReform Ltd. Confirms Sutures Compatibility in Human Clinical Trials for PRF-110 - GlobeNewsWire
- 4 weeks ago - PainReform Announces Exercise of Warrants for $1.58 Million Gross Proceeds - GlobeNewsWire
- 7 weeks ago - PainReform Announces Positive Safety Profile for PRF-110 in Phase 3 Bunionectomy Study - GlobeNewsWire
- 2 months ago - PainReform Announces Favorable Safety Profile of PRF-110, Indicating Potential for Use in New Surgical Applications Requiring Higher Doses - GlobeNewsWire
- 2 months ago - PainReform's New Manufacturing Process Achieves Significant Benefits Including 18-Month Stability of PRF-110 at Room Temperature - GlobeNewsWire
- 4 months ago - PainReform Announces Receipt of Nasdaq Minimum Bid Price Notification - GlobeNewsWire
- 5 months ago - PainReform Provides Business Update for the First Quarter of 2024 - GlobeNewsWire
- 5 months ago - PainReform CEO Ilan Hadar Discusses Latest Developments Related to PRF-110 and its Potential to Help Tackle the Opioid Epidemic on Proactiveinvestors.com - GlobeNewsWire